Amifampridine tablets are indicated for the treatment of Lambert-Eaton myasthenic syndrome in adults and pediatric patients 6 ...
Lupin Limited today announced that it has received tentative approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for Amifampridine Tablets, 10 mg.
Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New ...
The approval allows Lupin to enter the market for LEMS, rare autoimmune neuromuscular disorder affecting communication between nerve & muscle ...
16h
Teacher Retirement System of Texas lifted its stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 18.7% during the 4th quarter, according to the company in its most recent filing ...
On Monday, 1608 stocks advanced, 2503 declined and 130 remained unchanged on Bombay Stock Exchange with advance decline ratio ...
Equities research analysts at Zacks Research reduced their FY2025 earnings per share (EPS) estimates for Catalyst ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback